- In front of an assembly of international surgeons, three opinion leaders will lead a debate on the best treatments for spinal fractures
- Segment leader, Safe Orthopaedics will present the benefits of "SteriSpine", its minimally invasive, ready-to-use product range
Regulatory News:
SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 SAFOR), a company specialized in the design and marketing of single-use implants and instruments improving the minimally invasive treatment of spinal fracture conditions, will be present at the Eurospine 2018 Annual Conference taking place in Barcelona (Spain) from September 19 to 21, 2018. On this occasion, the company organizes a "Workshop" on spinal fractures.
Such fractures, whether they are accidental or related to osteoporosis, represent a dual challenge for surgeons: emergency treatment of patients and choosing the most appropriate surgical technique. How to enable a fast return to activity and reduce the risk of subsequent surgeries in the medium and long term will be issues discussed during the conference entitled "Spinal fracture treatment: challenges solutions", led by the company at EuroSpine on Thursday September 20, 2018 at 12:00 with presentations by the following opinion leaders:
Pr Jean-Charles Le Huec (CHU de Bordeaux, France)
Dr Steven Van Gaalen (Acibadem, International Medical Center, Amsterdam, The Netherlands)
Dr Andreas Demetriades (BMI Fernbrae Hospital, Dundee, Scotland)
"We are very happy to organize this second workshop on fractures at EuroSpine 2018 in front of the world's leading spine specialists. Discussing treatments for better fracture care is an opportunity for us to strengthen our strategy as segment leader: to highlight the benefits of our existing minimally invasive technologies and to reflect on the technologies of tomorrow" noted Pierre Dumouchel, Chief Executive Officer and co-founder of Safe Orthopaedics "As previously announced, the commercial launch of the SteriSpine VA vertebral augmentation technology establishes Safe Orthopaedics as the only manufacturer of ready-to-use technologies covering all spinal fractures and gives the company a strong growth vector for the years to come".
About EuroSpine
The EUROSPINE annual meeting and conference is the scientific highlight of the year for all spine professionals and experts in Europe.
It is the largest European community dealing with the spine and shows a steadily increasing number of members. In 2017, more than 2,300 surgeons from more than 80 countries attended the conference to learn about the latest advances in spinal surgery in order to improve patient care and ensure the best possible outcomes.
About Safe Orthopaedics
Founded in 2010, Safe Orthopaedics is a French medical technology company that offers the safest technologies to treat spinal fracture. Delivered sterile, all implants and respective disposable instrumentation are available to the surgeon at any time, any place. These technologies enable minimally invasive approaches, reducing risks of cross contamination and infection in the interest of the patient. Protected by 17 patent families, the SteriSpineTM Kits are CE marked and FDA cleared. The company is based at Eragny-Sur-Oise (France), and has 37 employees.
For more information: www.SafeOrtho.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180919005542/en/
Contacts:
Safe Orthopaedics
François-Henri Reynaud, Phone: +33 (0)1 34 21 50 00
CFO
investors@safeorthopaedics.com
or
Investor Relations
NewCap
Valentine Brouchot, Phone: +33 (0)1 44 71 94 94
SafeOrtho@newcap.eu
or
Press Relations
Ulysse Communication
Bruno Arabian, +33 (0)6 87 88 47 26
barabian@ulysse-communication.com
or
Nicolas Daniels, +33 (0)6 63 66 59 22
ndaniels@ulysse-communication.com